INO · Inovio Pharmaceuticals, Inc.
$1.10
+0.01 (+0.92%)
At close · Jul 21
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In light of these factors, management believes that there is substantial doubt about the Company's ability to continue as a going concern beyond the late fourth quarter of 2026.”View the 10-Q filed May 13, 2026
Market Cap
$90.50M
Shares
82.27M
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
67/100
Short interest 18.3% of shares — P97
Days to cover 10.4 — P95
Price vs VWAP -12.5% — P24
Short-volume trend -4.6% — P34
Short interest change -7.2% — P29
Worst FTD 0.11% of shares — P76
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 15,043,165 | 16,203,479 | -1,160,314 | 10.42 |
| 2026-06-15 | 16,203,479 | 16,268,843 | -65,364 | 10.78 |
| 2026-05-29 | 16,268,843 | 15,979,651 | +289,192 | 5.80 |
| 2026-05-15 | 15,979,651 | 14,235,596 | +1,744,055 | 3.17 |
| 2026-04-30 | 14,235,596 | 12,768,874 | +1,466,722 | 9.80 |
| 2026-04-15 | 12,768,874 | 9,884,839 | +2,884,035 | 2.71 |
| 2026-03-31 | 9,884,839 | 10,757,832 | -872,993 | 12.04 |
| 2026-03-13 | 10,757,832 | 10,960,650 | -202,818 | 14.79 |
| 2026-02-27 | 10,960,650 | 11,418,437 | -457,787 | 14.39 |
| 2026-02-13 | 11,418,437 | 12,450,335 | -1,031,898 | 10.09 |
| 2026-01-30 | 12,450,335 | 11,694,010 | +756,325 | 12.53 |
| 2026-01-15 | 11,694,010 | 9,867,930 | +1,826,080 | 5.85 |
| 2025-12-31 | 9,867,930 | 9,445,637 | +422,293 | 4.36 |
| 2025-12-15 | 9,445,637 | 8,629,046 | +816,591 | 7.74 |
| 2025-11-28 | 8,629,046 | 8,259,257 | +369,789 | 8.63 |
| 2025-11-14 | 8,259,257 | 8,209,858 | +49,399 | 4.89 |
| 2025-10-31 | 8,209,858 | 7,580,599 | +629,259 | 8.00 |
| 2025-10-15 | 7,580,599 | 7,626,088 | -45,489 | 7.53 |
| 2025-09-30 | 7,626,088 | 7,493,206 | +132,882 | 8.19 |
| 2025-09-15 | 7,493,206 | 6,594,846 | +898,360 | 3.61 |
| 2025-08-29 | 6,594,846 | 5,633,794 | +961,052 | 2.91 |
| 2025-08-15 | 5,633,794 | 5,096,499 | +537,295 | 2.62 |
| 2025-07-31 | 5,096,499 | 5,987,719 | -891,220 | 3.37 |
Showing 1–23 of 23 settlements
Key facts
CIK
1055726
CUSIP
45773H409
13F (30d)
10 filings
10 filers
Visit website
Investor relations